The latest genitourinary oncology news
Penile squamous cell carcinoma: improving outcomes
Penile squamous cell carcinoma is a rare malignancy with limited treatment options and poor prognosis,…
The latest genitourinary oncology news
Penile squamous cell carcinoma is a rare malignancy with limited treatment options and poor prognosis,…
Patient-reported outcomes are important indicators of how cancer drugs impact patients’ lives. By assessing the…
Patients with muscle-invasive urothelial cancer and a high risk of recurrence after surgery may have…
Subcutaneous injection of the immunotherapy nivolumab is non-inferior to intravenous delivery and dramatically reduces treatment…
Patients with metastatic castration-resistant prostate cancer (mCRPC) with extrapelvic nodal or visceral metastasis who were…
More than 65,000 men fall ill with prostate cancer each year in Germany. Twelve thousand…
Considering the molecular subtype of muscle-invasive bladder cancer (MIBC) based on differences in tumour RNA…
A clinical trial co-led by Mount Sinai researchers is the first to show that using chemotherapy…
The Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group recently held another…
Hear from some of the world’s leading below the belt researchers and patients through ANZUP’s…